Patient Guide: A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 181 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03839771
Status: ACTIVE_NOT_RECRUITING
Condition: Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2
Phase: PHASE3

Find a Study Location Near You

This study is available at 181 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Adelaide,
  • Adelaide,
  • Brisbane,
  • • And 178 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily